Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Arlehamn CSL, Sette A.

Nature. 2017 Sep 13;549(7671):292. doi: 10.1038/nature23896.

PMID:
28905919
2.

T cells from patients with Parkinson's disease recognize α-synuclein peptides.

Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, Dawson VL, Dawson TM, Oseroff C, Pham J, Sidney J, Dillon MB, Carpenter C, Weiskopf D, Phillips E, Mallal S, Peters B, Frazier A, Lindestam Arlehamn CS, Sette A.

Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21. Erratum in: Nature. 2017 Sep 13;549(7671):292.

3.

Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.

Oseroff C, Pham J, Frazier A, Hinz D, Sidney J, Paul S, Greenbaum JA, Vita R, Peters B, Schulten V, Sette A.

Ann Allergy Asthma Immunol. 2016 Dec;117(6):680-689.e1. doi: 10.1016/j.anai.2016.10.014. Erratum in: Ann Allergy Asthma Immunol. 2017 Mar;118(3):384.

4.

Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity.

Oseroff C, Christensen LH, Westernberg L, Pham J, Lane J, Paul S, Greenbaum J, Stranzl T, Lund G, Hoof I, Holm J, Würtzen PA, Meno KH, Frazier A, Schulten V, Andersen PS, Peters B, Sette A.

Clin Exp Allergy. 2017 Apr;47(4):577-592. doi: 10.1111/cea.12829. Epub 2016 Nov 7.

5.

Sequence conservation predicts T cell reactivity against ragweed allergens.

Pham J, Oseroff C, Hinz D, Sidney J, Paul S, Greenbaum J, Vita R, Phillips E, Mallal S, Peters B, Sette A.

Clin Exp Allergy. 2016 Sep;46(9):1194-205. doi: 10.1111/cea.12772. Epub 2016 Jul 26.

6.

Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.

Hinz D, Seumois G, Gholami AM, Greenbaum JA, Lane J, White B, Broide DH, Schulten V, Sidney J, Bakhru P, Oseroff C, Wambre E, James EA, Kwok WW, Peters B, Vijayanand P, Sette A.

Clin Exp Allergy. 2016 May;46(5):705-19. doi: 10.1111/cea.12692.

7.

Different Bla-g T cell antigens dominate responses in asthma versus rhinitis subjects.

Dillon MB, Schulten V, Oseroff C, Paul S, Dullanty LM, Frazier A, Belles X, Piulachs MD, Visness C, Bacharier L, Bloomberg GR, Busse P, Sidney J, Peters B, Sette A.

Clin Exp Allergy. 2015 Dec;45(12):1856-67. doi: 10.1111/cea.12643.

8.

The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.

Bergmann T, Moore C, Sidney J, Miller D, Tallmadge R, Harman RM, Oseroff C, Wriston A, Shabanowitz J, Hunt DF, Osterrieder N, Peters B, Antczak DF, Sette A.

Immunogenetics. 2015 Nov;67(11-12):675-89. doi: 10.1007/s00251-015-0872-z. Epub 2015 Sep 23.

9.

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.

Paul S, Lindestam Arlehamn CS, Scriba TJ, Dillon MB, Oseroff C, Hinz D, McKinney DM, Carrasco Pro S, Sidney J, Peters B, Sette A.

J Immunol Methods. 2015 Jul;422:28-34. doi: 10.1016/j.jim.2015.03.022. Epub 2015 Apr 7.

10.

Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens.

Hinz D, Oseroff C, Pham J, Sidney J, Peters B, Sette A.

Clin Exp Allergy. 2015 Oct;45(10):1601-12. doi: 10.1111/cea.12507.

11.

Allergy-associated T cell epitope repertoires are surprisingly diverse and include non-IgE reactive antigens.

Frazier A, Schulten V, Hinz D, Oseroff C, Sidney J, Peters B, Sette A.

World Allergy Organ J. 2014 Oct 22;7(1):26. doi: 10.1186/1939-4551-7-26. eCollection 2014. Review.

12.

Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE Jr, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S.

J Clin Invest. 2013 May;123(5):1976-87. doi: 10.1172/JCI67388. Epub 2013 Apr 1.

13.

Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals.

Schulten V, Greenbaum JA, Hauser M, McKinney DM, Sidney J, Kolla R, Lindestam Arlehamn CS, Oseroff C, Alam R, Broide DH, Ferreira F, Grey HM, Sette A, Peters B.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3459-64. doi: 10.1073/pnas.1300512110. Epub 2013 Feb 11. Erratum in: Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5269. Ferreira-Briza, Fatima [corrected to Ferreira, Fatima]. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8750.

14.

A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.

McKinney DM, Southwood S, Hinz D, Oseroff C, Arlehamn CS, Schulten V, Taplitz R, Broide D, Hanekom WA, Scriba TJ, Wood R, Alam R, Peters B, Sidney J, Sette A.

Immunogenetics. 2013 May;65(5):357-70. doi: 10.1007/s00251-013-0684-y. Epub 2013 Feb 8.

15.

Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey HM, Sette A.

Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.. doi: 10.1002/0471142735.im1803s100.

16.

The identification of potentially pathogenic and therapeutic epitopes from common human allergens.

Schulten V, Oseroff C, Alam R, Broide D, Vijayanand P, Peters B, Sette A.

Ann Allergy Asthma Immunol. 2013 Jan;110(1):7-10. doi: 10.1016/j.anai.2012.10.015. Epub 2012 Nov 15. Review.

17.

T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts.

Oseroff C, Sidney J, Vita R, Tripple V, McKinney DM, Southwood S, Brodie TM, Sallusto F, Grey H, Alam R, Broide D, Greenbaum JA, Kolla R, Peters B, Sette A.

J Immunol. 2012 Aug 15;189(4):1800-11. doi: 10.4049/jimmunol.1200850. Epub 2012 Jul 11.

18.

Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production.

Oseroff C, Sidney J, Tripple V, Grey H, Wood R, Broide DH, Greenbaum J, Kolla R, Peters B, Pomés A, Sette A.

J Immunol. 2012 Jul 15;189(2):679-88. doi: 10.4049/jimmunol.1200694. Epub 2012 Jun 15.

19.

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64. doi: 10.1073/pnas.1207934109. Epub 2012 May 29.

20.

Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.

Oseroff C, Sidney J, Kotturi MF, Kolla R, Alam R, Broide DH, Wasserman SI, Weiskopf D, McKinney DM, Chung JL, Petersen A, Grey H, Peters B, Sette A.

J Immunol. 2010 Jul 15;185(2):943-55. doi: 10.4049/jimmunol.1000405. Epub 2010 Jun 16.

21.

Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage.

Kotturi MF, Botten J, Maybeno M, Sidney J, Glenn J, Bui HH, Oseroff C, Crotty S, Peters B, Grey H, Altmann DM, Buchmeier MJ, Sette A.

Immunome Res. 2010 May 17;6:4. doi: 10.1186/1745-7580-6-4.

22.

A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.

Kotturi MF, Botten J, Sidney J, Bui HH, Giancola L, Maybeno M, Babin J, Oseroff C, Pasquetto V, Greenbaum JA, Peters B, Ting J, Do D, Vang L, Alexander J, Grey H, Buchmeier MJ, Sette A.

PLoS Pathog. 2009 Dec;5(12):e1000695. doi: 10.1371/journal.ppat.1000695. Epub 2009 Dec 18.

23.

Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Sette A, Grey H, Oseroff C, Peters B, Moutaftsi M, Crotty S, Assarsson E, Greenbaum J, Kim Y, Kolla R, Tscharke D, Koelle D, Johnson RP, Blum J, Head S, Sidney J.

Vaccine. 2009 Dec 30;27 Suppl 6:G21-6. doi: 10.1016/j.vaccine.2009.10.011. Review.

24.

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.

Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R, Ponomarenko J, Scheuermann RH, Sette A, Peters B.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70. doi: 10.1073/pnas.0911580106. Epub 2009 Nov 16.

25.

Quantitating T cell cross-reactivity for unrelated peptide antigens.

Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, Wang L, Dong T, Pasquetto V, Oseroff C, Sidney J, Hickman H, Cerundolo V, Sette A, Bennink JR, McMichael A, Yewdell JW.

J Immunol. 2009 Oct 1;183(7):4337-45. doi: 10.4049/jimmunol.0901607. Epub 2009 Sep 4.

26.

Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?

Kotturi MF, Assarsson E, Peters B, Grey H, Oseroff C, Pasquetto V, Sette A.

Immunome Res. 2009 Jun 17;5:3. doi: 10.1186/1745-7580-5-3.

27.

Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans.

Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A.

J Virol. 2008 Dec;82(24):12241-51. doi: 10.1128/JVI.01563-08. Epub 2008 Oct 8.

28.

Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Dow C, Oseroff C, Peters B, Nance-Sotelo C, Sidney J, Buchmeier M, Sette A, Mothé BR.

J Virol. 2008 Dec;82(23):11734-41. doi: 10.1128/JVI.00435-08. Epub 2008 Oct 1.

29.

Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

Oseroff C, Peters B, Pasquetto V, Moutaftsi M, Sidney J, Panchanathan V, Tscharke DC, Maillere B, Grey H, Sette A.

J Immunol. 2008 Jun 1;180(11):7193-202.

30.

Measurement of MHC/peptide interactions by gel filtration.

Sidney J, Southwood S, Oseroff C, del Guercio MF, Sette A, Grey HM.

Curr Protoc Immunol. 2001 May;Chapter 18:Unit 18.3. doi: 10.1002/0471142735.im1803s31.

PMID:
18432745
31.

Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Assarsson E, Greenbaum JA, Sundström M, Schaffer L, Hammond JA, Pasquetto V, Oseroff C, Hendrickson RC, Lefkowitz EJ, Tscharke DC, Sidney J, Grey HM, Head SR, Peters B, Sette A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5. doi: 10.1073/pnas.0711573105. Epub 2008 Feb 1. Erratum in: Proc Natl Acad Sci U S A. 2008 May 6;105(18):6787.

32.

Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes.

Mothé BR, Stewart BS, Oseroff C, Bui HH, Stogiera S, Garcia Z, Dow C, Rodriguez-Carreno MP, Kotturi M, Pasquetto V, Botten J, Crotty S, Janssen E, Buchmeier MJ, Sette A.

J Immunol. 2007 Jul 15;179(2):1058-67.

33.

A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.

Assarsson E, Sidney J, Oseroff C, Pasquetto V, Bui HH, Frahm N, Brander C, Peters B, Grey H, Sette A.

J Immunol. 2007 Jun 15;178(12):7890-901.

34.

Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.

Moutaftsi M, Bui HH, Peters B, Sidney J, Salek-Ardakani S, Oseroff C, Pasquetto V, Crotty S, Croft M, Lefkowitz EJ, Grey H, Sette A.

J Immunol. 2007 Jun 1;178(11):6814-20.

35.

The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.

Kotturi MF, Peters B, Buendia-Laysa F Jr, Sidney J, Oseroff C, Botten J, Grey H, Buchmeier MJ, Sette A.

J Virol. 2007 May;81(10):4928-40. Epub 2007 Feb 28.

36.

HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.

Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, Peters B, Southwood S, Cerundolo V, Grey H, Yewdell JW, Sette A.

J Immunol. 2005 Oct 15;175(8):5504-15. Erratum in: J Immunol. 2005 Dec 15;175(12):8440. Banh, Cindy [added].

37.

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Oseroff C, Kos F, Bui HH, Peters B, Pasquetto V, Glenn J, Palmore T, Sidney J, Tscharke DC, Bennink JR, Southwood S, Grey HM, Yewdell JW, Sette A.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13980-5. Epub 2005 Sep 19.

38.
39.

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.

Alexander J, Oseroff C, Dahlberg C, Qin M, Ishioka G, Beebe M, Fikes J, Newman M, Chesnut RW, Morton PA, Fok K, Appella E, Sette A.

J Immunol. 2002 Jun 15;168(12):6189-98.

40.

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.

Sette AD, Oseroff C, Sidney J, Alexander J, Chesnut RW, Kakimi K, Guidotti LG, Chisari FV.

J Immunol. 2001 Jan 15;166(2):1389-97.

41.

Human memory CTL response specific for influenza A virus is broad and multispecific.

Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A.

Hum Immunol. 2000 May;61(5):438-52.

PMID:
10773346
42.

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A.

J Immunol. 1999 Apr 1;162(7):3915-25.

43.

Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG, Chisari FV, Fikes J, Chesnut RW, Sette A.

J Immunol. 1999 Mar 1;162(5):3088-95.

44.

Lipopeptide particles as the immunologically active component of CTL inducing vaccines.

Tsunoda I, Sette A, Fujinami RS, Oseroff C, Ruppert J, Dahlberg C, Southwood S, Arrhenius T, Kuang LQ, Kubo RT, Chesnut RW, Ishioka GY.

Vaccine. 1999 Feb 26;17(7-8):675-85.

PMID:
10067673
45.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J.

Vaccine. 1998 May;16(8):823-33.

PMID:
9627940
46.

Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.

van der Most RG, Murali-Krishna K, Whitton JL, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Sette A, Ahmed R.

Virology. 1998 Jan 5;240(1):158-67.

47.

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A.

J Immunol. 1997 Nov 15;159(10):4753-61. Erratum in: J Immunol 1999 Mar 1;162(5):3104.

PMID:
9366399
48.

Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice.

van der Most RG, Concepcion RJ, Oseroff C, Alexander J, Southwood S, Sidney J, Chesnut RW, Ahmed R, Sette A.

J Virol. 1997 Jul;71(7):5110-4.

49.

Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.

van der Most RG, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau LL, Southwood S, Sidney J, Chesnut RW, Matloubian M, Ahmed R.

J Immunol. 1996 Dec 15;157(12):5543-54.

PMID:
8955205
50.

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM.

J Immunol. 1995 Jun 1;154(11):5934-43.

PMID:
7538538

Supplemental Content

Loading ...
Support Center